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The aim ofthis studywas to evaluate the effect on human lymphocyte chromosomes ofthe 1311 dosage usedin scintigraphy on thyroidpatients. Until now, there has been as absence
ofconclusive reports on the effectsproducedbysuch dosage. Samples were obtainedfrom
21 patients, and the blood was collected in two occasions: Twenty-fourhours prior(control)
and afteradministration ofthe radionuclide (test). Cells wereplacedin 1640 RPMImedium
with bovine calfserum and incubated with phytohaemagglutinin for48 and 72 hrat 370C.
Chromosomes were stained with Giemsa Gurr (2 percent, pH = 6.8), and analyzed by two
independent investigators by optical microscopy. Ofthe 6,300 metaphases analyzed from
the 48- and 72-hr cultures, 1,146 and 216 gaps and 682 and 52 breaks were found in the
test group, respectively. Of the 6,300 metaphases analyzed from the control group, 291
gaps and 119 breaks were observedin the 48-hrcultures whereas in the 72-hrcultures, 10
gaps, and no breaks were found. Ourresults show that 1311 is responsible forthe observed
chromosome alterations (paired t-test, p < .05). We suggest re-evaluating the use of 1311
and replacing it with the 1, mainly on those patients at fertile age.
INTRODUCTION
Chromosomes are long strands of
deoxyribonucleic acid (DNA)d in a dou-
ble-stranded helical configuration. Each
human lymphocyte has 46 chromosomes
in 23 pairs. A chromosome contains about
100,000 genes, and each gene about 1000
nucleotides. Chromosomes, with their
large molecular structure, undergo com-
plex reactions during their duplication,
segregation, and differentiation. This
structure can be altered by many physical
and chemical reactions [1].
Two types ofchromosomal abnormal-
ities are described: (a) changes in structur-
al and (b) changes in the chromosome
number. Both of these cause genetic dis-
turbances in the cell. Agents that cause
chromosomal breakage are clastogens and
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those causing numerical changes are
mitotic poisons [2].
There are four types ofalterations due
to chromosome breakage: acentric frag-
ments, minutes, rings, and dicentrics.
Acentric fragments result from simple
breaks across the chromosome, while min-
utes are usually produced from two breaks
close together. Rings are the result of
exchange between two breaks on the chro-
mosomes. Dicentrics result from an
exchange between two broken chromo-
somes, yielding a chromosome with two
centromeres and an acentric fragment. The
first three kinds of aberrations involve
changes within a single chromosome and
result in the loss of a chromosome frag-
ment at mitosis. If the loss is large, it will
be lethal. Ifthe loss is small, however, the
cell may be viable and transmit the defi-
ciency to the daughter cell. Dicentric aber-
rations, involving two chromosomes, are
usually lethal. Since DNA dominates the
growth and differentiation of the cell,
alterations in DNA strands may be serious
and can lead to mutations or oncogenesis.
Spontaneous aberrations have been found
in all normal populations. The incidence
varies with age, geographic location, and
smoking habits [1].
According to Schwartz, 1998 [3],
there are many variables thatcan influence
radiation sensitivity and that might
account for inter-individual differences in
radiation sensitivity. These include varia-
tions in sensitivity to induction of DNA
damage, changes in DNA repair, in cell
growth and in proportions of cells in dif-
ferent phases ofthe cell cycle, in cell cycle
checkpoint response, and in DNAcontent.
Each parameter has been shown to vary
from cell to cell, and in some cases rough
correlations between one or more vari-
ables and radiation sensitivity have been
reported. For example, diploid cells tend
to be more radiosensitive than aneuploid
cells, and more radiosensitive cells have
sometimes been shown to grow more
slowly than more resistant cells. There is,
however, a growing body ofevidence sug-
gesting that alterations in the rate, fidelity,
and total fraction of DNA double-strand
breaks repaired in a cell is the primary fac-
tor underlying the differences in sensitivi-
ty, both histology-based and inter-individ-
ual. Furthermore, these variations in repair
may be related to alterations in chromo-
some structure or organization [3].
Radioactive iodine scintigraphy is
commonly used for diagnostic of thyroid
diseases. 131I is a B emitter with a mixture
ofy-rays, which has a half-life ofapproxi-
mately eight days. It has been postulated
that around 90 percent of the radiation
effects are a result ofthe B-radiation [4].
It is difficult to establish an accurate
relationship between low doses of radia-
tion and biological effects [4]. Thus, in
this paper we show the results of cytoge-
netic analysis ofpatients that were submit-
ted to thyroid scintigraphy with 1311.
PATIENTS AND METHODS
Twenty-one patients with suspicion of
thyroid diseases aged 21 to 79 years, from
Servico de Endocrinologia, Hospital
Universitario Clementino Fraga Filho, Rio
de Janeiro, Brazil, were submitted to thy-
roid scintigraphy with 1311. The indica-
tions for examination were hyperthy-
roidism, nodular goiter, Grave's disease,
and multinodular goiter. The institutional
review board approved the study protocol.
Fully-informed written consent was
obtained from all patients. The patients
answered a questionnaire including infor-
mation on smoking habits, drug intake,
exposure to ionizing radiation, alcoholic
intake, and clastogenic drugs. Those sub-
jects who had been taking drugs or had
been exposed to radiation fordiagnostic or
therapeutical purposes were excluded.
The radionuclide 1311, with a mean
activity of 3.7 MBq was orally adminis-
tered to these patients.Rodrigues et al.: 1311 Effects on chromosomes 111
The same individual provided the
control and the test samples. For this, two
blood samples were withdrawn in sterile
heparinized tubes from each subject in a
follow-up study. The first sample was
obtained before the 131I administration and
was used as control. The test sample was
taken 24 hr after the 131I administration.
Cells in metaphases were obtained by
stimulating blood cells with phytohaemag-
glutinin in RPMI 1640 medium with 20
percent calfserum. Cultures from both test
and control samples were incubated for48
and 72 hr at 370C. All the cultures and
slides for the chromosome aberration
assay were prepared following a modifica-
tion of the technique described by
Moorehead, 1960 [5].
Three hundred well-spread metaphas-
es were analyzed for each incubation time
and for each subject. Chromosome aberra-
tions were scored according to Bender et
al., 1988 [6], by two independent investi-
gators; disagreement was resolved by a
third reviewer and consensus. Slides were
coded during analysis in a blind study,
without knowledge whether the slides
were from test or control groups.
Chromosomes were analyzed by light
microscopy, and photomicrographs were
taken when needed. Data were statistically
analyzed by paired t-test.
RESULTS
Samples from 21 patients with differ-
ent underlying thyroid dysfunctions were
analyzed with regard to chromosomal
abnormalities following 131I treatment,
using as controls their own blood samples
taken before treatment.
A total of 25,200 metaphases were
scored, corresponding to 300 metaphases
per patient, per point. Of the 6,300
metaphases analyzed from the control
samples, after 48 hr in culture, 5,890 were
normal, and only 410 were abnormal, with
291 gaps and 119 breaks observed. Ofthe
6,300 metaphases analyzed from the test
samples 1828 were abnormal with 1,146
gaps and 682 breaks while the other 4,472
metaphases were considered as normal. In
the 72-hr cultures, only 10 metaphases of
the 6,300 analyzed from the control sam-
ples were abnormal. On the other hand, in
test samples, 268 metaphases were abnor-
mal with 216 gaps and 52 breaks. The
other 6,032 metaphases were considered
as normal. The 48- and 72- hr distribution
of normal and abnormal metaphases from
control and test groups can be observed in
Figure 1.
Table 1 shows the distribution ofgaps
and breaks found in abnormal metaphases
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Figure 2 (left). Chromosomes from a patient treated with 1311. The arrow indicates a
gap. Figure 3 (right). Chromosomes from a patient treated with 1311. The arrow indi-
cates a break.
72-hr cultures. Figures 2 and 3 show chro-
mosomal studies with a gap and a break,
respectively.
DISCUSSION
There are a number of studies corre-
lating biological dosimetry and cytogenet-
ic analysis, including studies relative to:
clinical exposure [7-10], nuclear accidents
[11, 12] and occupational exposure [13-
16]. All these reports involve people that
have received high dosages of ionizing
radiation.
The importance of the present study
refers to the paucity ofstudies on the cyto-
genetic effects produced by low ionizing
radiation dosages (3.7 MBq of 1311). Only
one similar study using cytogenetic analy-
sis of low ionizing radiation dosages of
99mTc in vitro was described [17].
In our study, a number of abnormal
metaphases, significantly different from
those seen in control samples, were seen in
lymphocytes obtained from patients 24 hr
after they had been exposed to 1311I. The
chromosomal alterations observed were
gaps and breaks. It has been described that
the incubation period can affect the fre-
quency of chromosomal aberrations [16,
18]. We observed that the frequency of
chromosomal alterations decreased with
the increase of the incubation time, from
48 to 72 hr. This could be explained by
anaphases loss of abnormal chromosomes
during mitosis.
Table 1. Abnormal metaphases results in 48 and 72-hr cultures.
Test group Control
48 hr 72 hr 48 hr 72 hr Total
Gaps 1146 216 291 10 1663
Breaks 682 52 119 0 853
Total 1828 268 410 10 2516Rodrigues et al.: 1311 Effects on chromosomes 113
Chromosomes are extremely thin at
the gap region. This may facilitate the
occurrence ofbreaks. Despite being a seri-
ous chromosomal aberration, DNA repair
can occur at the gap region and the capac-
ity to repair will depend on individual dif-
ferences in radiation sensitivity [14]. In
the case of induced aberrations, as
described here, there was a significant
increase of gap and this probably can sat-
urate the natural repair mechanism [7, 17,
19, 20].
Breaks are chromosomal alterations
where complete separation ofachromoso-
mal region occurs. Since DNA is com-
pletely interrupted in that region, there is
no possibility of repair, facilitating the
occurrence ofdeletions and translocations.
Due to their stability, translocations are
not only important for biodosimetry, but
are implicated in cancer and a variety of
genetic diseases and, thus, represent a risk
to health [21]. Like gaps, the breaks were
significantly increased after the 1311
administration, at both incubation periods
oftime [15, 22], as shown in Table 1.
Although in a lesser amount, the same
types of chromosomal alterations were
also found in control samples (48 and 72
hr), however, there were no chromosomal
breaks at 72 hr. The decrease in the num-
ber of gaps and breaks in 72-hr cultures,
both in test and control samples, might be
explained by the loss ofabnormal chromo-
somes after 48-hr cultures and also by the
cells natural repair mechanism.
A large proportion of the radiation
damage to chromosomes is repaired spon-
taneously within 30 to 90 min.
Nevertheless, some chromosomal aberra-
tions may persist for many years. For
example, one group ofspondylitic patients
who had received 1500 rad ofpartial-body
irradiation (whole spine and sacroiliac
joints) was followed for 20 years by
Buckton et al. The cytogenetic changes in
blood lymphocytes persisted during the
entire period but with a progressively
decreasing frequency. The cytogenetic
damage was probably induced in the stem
cells of the irradiated marrow. These
authors considered the relationship
between the cell damage and increased
frequency ofmalignancies an enigma [1].
Early investigators ofhuman chromo-
somes thought that aberrations were initi-
ating events of the neoplastic process.
Recently, however, some authors conclud-
ed that most chromosomal disturbances do
not lead to cancer. Nowell believed that it
was impossible to identify which individu-
als will eventually develop leukemia on
the basis of chromosomal abnormalities
[23]. Furthermore, he regarded aberrations
in a single analysis as insufficient evidence
that an individual is at risk. Finally he con-
sidered chromosomal aberrations pro-
duced by radiation, viruses, or chemicals
as relatively crude indicators of genetic
and carcinogenic consequences. Ofcourse,
no aberrant chromosomes are desirable,
but their incidence is ubiquitous [1].
More studies are needed on the fate of
irradiated peripheral-blood lymphocytes.
However, our results indicate that low
dosages of 1311 (3.7 MBq), administrated
to patients for scintigraphy of the thyroid,
may cause chromosomal aberrations. We
suggest re-evaluating the use of 1311,
replacing it with 1231, mainly onpatients of
fertile age.
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